New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 3, 2013
10:07 EDTXNCRXencor opens for trade at $5.95, IPO priced at $5.50
Xencor (XNCR) priced 12.7M shares at $5.50. Credit Suisse and Leerink acted as joint book running managers for the offering.
News For XNCR From The Last 14 Days
Check below for free stories on XNCR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2014
08:03 EDTXNCRXencor Merck receives milestone payment from Merck for using XmAb antibody
Xencor (XNCR) announced that the company has received a milestone payment from Merck (MRK), through a subsidiary, triggered by the initiation of a Phase 1 clinical trial for an undisclosed biologic drug candidate that uses Xencor's XmAb antibody engineering intellectual property. Under the terms of the agreement signed in June 2013, Xencor granted Merck a non-exclusive license to certain Xencor patents for use in an undisclosed product, as well as an option to license the same intellectual property for future products. Xencor received an upfront payment and continues to receive annual maintenance fees. Xencor is also eligible to receive milestone payments associated with the successful development of Merck product candidates, as well as royalties on sales of any potential products that may result from this agreement.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use